Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database

Emerging targets of disease-modifying therapy for systemic sclerosis

(2019) Elizabeth R. Volkmann et al.   Nature Reviews Rheumatology

An Autoimmune Basis for Raynaud's Phenomenon: Murine Model and Human Disease

(2018) D. P. Ascherman et al.   Arthritis & Rheumatology

Review of Drug Repositioning Approaches and Resources

(2018) Hanqing Xue et al.   International Journal of Biological Sciences

Drug repurposing: progress, challenges and recommendations

(2018) Sudeep Pushpakom et al.   NATURE REVIEWS DRUG DISCOVERY

Points to consider—Raynaud’s phenomenon in systemic sclerosis

(2017) Maurizio Cutolo et al.   RHEUMATOLOGY

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

(2017) Christopher P. Denton et al.   Arthritis & Rheumatology

VigiBase, the WHO Global ICSR Database System: Basic Facts

(2017) Marie Lindquist   DRUG INFORMATION JOURNAL

Update of EULAR recommendations for the treatment of systemic sclerosis

(2016) Otylia Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers

(2016) Charles Khouri et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis

(2016) Dinesh Khanna et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Raynaud’s Phenomenon

(2016) Fredrick M. Wigley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning

(2014) Hao Ye et al.   PLoS One

Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin

(2012) Julien Hanson et al.   PHARMACOLOGY & THERAPEUTICS

Dissolution point and isolation robustness: Robustness criteria for general cluster analysis methods

(2007) Christian Hennig   JOURNAL OF MULTIVARIATE ANALYSIS